The Life Achievement Award 2024 has been awarded to Prof. Bertram Wiedenmann, Senior Professor at and former Head of the Department of Hepatology and Gastroenterology at Charité Medical School in Berlin, Germany.

Prof. Wiedenmann received his M.D. from the Technical University of Munich Medical School in 1980. He completed a Fulbright Research Fellowship in haematology at the Albert Einstein College of Medicine, NY, USA (1980-1982), was a Research Associate in Cell Biology at the Biological Laboratories, Harvard University (1982-1983), and at the German Cancer Research Center, Heidelberg, Germany (1983-1984). His major research interests comprise molecular and cell biology involving especially cellular signal transduction pathways in the field of gastrointestinal oncology.

Prof. Wiedenmann was chair of ASCO-GI in 2017 and is currently CMO of AutemTherapeutics, an American start-up company developing a novel oncological device. He is a member of several international and national societies, such as AGA, ASCO, and ESMO. He is the former chairman and long-term treasurer of the European Neuroendocrine Tumor Society (ENETS), former member of the steering committee of the Comprehensive Cancer Center Charité, and former coordinator of the site management organisation (SMO) for clinical studies (KKS Charité) at the Charité Medical School.

At the German Cancer Center, Heidelberg, Germany, Prof. Wiedenmann - together with Werner Franke - discovered the well-known tumor marker Synaptophysin. In addition to seven publications in Nature and its daughter journals, he has published more than 1,000 peer-reviewed papers and is a reviewer for many international and national journals.

Back to our Honorary Members